Featured Articles

  1. Reducing Lead Time & Optimizing Costs 8/2/2022

    Explore how the use of this component platform produces significant savings, reduces elastomer SKU complexity, and increases speed to market.

  2. West Introduces Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System At BIO International Convention 6/13/2022

    Daikyo Crystal Zenith® (CZ®) is a technologically advanced cyclic olefin polymer containment and delivery system that offers an alternative to glass, mitigating the risk of breakage and reducing the chance of particulates, contamination, and extractables.

  3. Global Pharmaceutical Packaging Manufacturer To Invest More Than $70 Million In Kinston Expansion 2/1/2022

    West Pharmaceutical Services, Inc. [NYSE: WST], a global leader in innovative solutions for injectable drug administration, will create approximately 70 jobs in Lenoir County, Governor Roy Cooper announced.

  4. West Announces Landmark Collaboration With Corning In Pharmaceutical Injectable Drug Delivery 1/26/2022

    The exclusive long-term supply and development agreement includes a multimillion-dollar capital and R&D investment in Corning to enable advanced drug containment and delivery system solutions.

  5. West Expands NovaGuard™ Platform of Products for Safe and Effective Injectable Drug Delivery 7/2/2013

    West Pharmaceutical Services, Inc., a leading global developer and manufacturer of components and systems for injectable drug delivery, today announced the expansion of the NovaGuard portfolio of needle safety products.

  6. The Importance Of A Human Centered Approach To Product Development

    To meet the needs of patients, life-saving device innovations are needed for the next generation of delivery devices. As drug manufacturers explore the device world, human factors are a key consideration.

  7. De-Risking Visible Particles Through Component Selection

    Explore a summary of the FDA’s recent draft guidance “Inspection of Injectable Products for Visible Particulates” and how it applies to components.

  8. Delivering Market Success For Pharma Partners From Concept To Patient

    The development of drug delivery devices that are innovative, intuitive, patient friendly, and patient safe must address certain areas of concern that are particular to both biologic and biosimilar therapies.

  9. Functional Performance Of Stoppers To Support Multipuncture Use

    Multi-dose vials enable dosing flexibility to a diverse group of patients with different dosages dependent on patient age/weight and can create efficiency and reduce packaging waste when vaccines are administered to large populations.

  10. Is It Ever Too Soon To Start Your Extractables And Leachables Assessment?

    Learn what you need to know about planning for your extractables and leachables testing programs to mitigate delays to your drug development timelines.